[
    [
        {
            "time": "2019-06-26",
            "original_text": "利空出尽+估值切换，医药板块年底或迎新一轮上涨趋势",
            "features": {
                "keywords": [
                    "利空出尽",
                    "估值切换",
                    "医药板块",
                    "上涨趋势"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "利空出尽+估值切换，医药板块年底或迎新一轮上涨趋势",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-06-26",
            "original_text": "外资动向 | 北向资金减仓A股 沪深股通净流出9.44亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "减仓",
                    "沪深股通",
                    "净流出"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "外资动向 | 北向资金减仓A股 沪深股通净流出9.44亿元",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-06-26",
            "original_text": "海外医药新闻发布20190626【西南医药朱国广陈铁林团队】",
            "features": {
                "keywords": [
                    "海外医药",
                    "新闻",
                    "西南医药",
                    "朱国广",
                    "陈铁林"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "海外医药新闻发布20190626【西南医药朱国广陈铁林团队】",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 2
            }
        },
        {
            "time": "2019-06-26",
            "original_text": "商誉超88亿的复星医药，拟7.4亿收购力思特",
            "features": {
                "keywords": [
                    "复星医药",
                    "商誉",
                    "收购",
                    "力思特"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "商誉超88亿的复星医药，拟7.4亿收购力思特",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-06-26",
            "original_text": "港股午盘基本平收 零售股、医药股现强势",
            "features": {
                "keywords": [
                    "港股",
                    "午盘",
                    "零售股",
                    "医药股",
                    "强势"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "零售"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股午盘基本平收 零售股、医药股现强势",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-06-26",
            "original_text": "医药板块表现强势，机构：不惧政策扰动，把握高确定性投资主线",
            "features": {
                "keywords": [
                    "医药板块",
                    "强势",
                    "政策扰动",
                    "高确定性",
                    "投资主线"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药板块表现强势，机构：不惧政策扰动，把握高确定性投资主线",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-06-26",
            "original_text": "中信证券清仓减持中信建投；新纶科技涉信披违规被证监会立案调查",
            "features": {
                "keywords": [
                    "中信证券",
                    "清仓减持",
                    "中信建投",
                    "新纶科技",
                    "信披违规",
                    "证监会",
                    "立案调查"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "中信证券清仓减持中信建投；新纶科技涉信披违规被证监会立案调查",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]